Skip to main content

Main menu

  • Content
    • Current Issue
    • Advance Access
    • Archive
    • Supplements
    • Special Collections
    • Topic Collections
  • For Authors
    • Instructions for Authors
    • Tips for Writing About Programs in GHSP
      • Local Voices Webinar
      • Connecting Creators and Users of Knowledge
    • Submit Manuscript
    • Publish a Supplement
    • Promote Your Article
    • Resources for Writing Journal Articles
  • About
    • About GHSP
    • Editorial Team
    • Advisory Board
    • FAQs
    • Instructions for Reviewers

User menu

  • My Alerts

Search

  • Advanced search
Global Health: Science and Practice
  • My Alerts

Global Health: Science and Practice

Dedicated to what works in global health programs

Advanced Search

  • Content
    • Current Issue
    • Advance Access
    • Archive
    • Supplements
    • Special Collections
    • Topic Collections
  • For Authors
    • Instructions for Authors
    • Tips for Writing About Programs in GHSP
    • Submit Manuscript
    • Publish a Supplement
    • Promote Your Article
    • Resources for Writing Journal Articles
  • About
    • About GHSP
    • Editorial Team
    • Advisory Board
    • FAQs
    • Instructions for Reviewers
  • Alerts
  • Find GHSP on LinkedIn
  • Visit GHSP on Facebook
  • RSS
REVIEW
Open Access

Preexposure Prophylaxis Among Pregnant and Lactating People in 18 PEPFAR-Supported Countries: A Review of HIV Strategies and Guidelines

Sheena Sharifi Abadan, Liz Hawryluk, Michele Montandon, Nicole Flowers, Jane Schueller, Robyn Eakle, Pragna Patel, Michelle S. Chevalier, Sangeeta Rana and Anouk Amzel
Global Health: Science and Practice December 2022, 10(6):e2200129; https://doi.org/10.9745/GHSP-D-22-00129
Sheena Sharifi Abadan
aU.S. Agency for International Development, Washington, DC, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liz Hawryluk
aU.S. Agency for International Development, Washington, DC, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michele Montandon
bU.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicole Flowers
bU.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jane Schueller
aU.S. Agency for International Development, Washington, DC, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robyn Eakle
aU.S. Agency for International Development, Washington, DC, USA.
cLondon School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pragna Patel
bU.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michelle S. Chevalier
dOffice of the Global AIDS Coordinator and Health Diplomacy, Washington DC, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sangeeta Rana
aU.S. Agency for International Development, Washington, DC, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anouk Amzel
aU.S. Agency for International Development, Washington, DC, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: aamzel{at}usaid.gov
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • Comments
  • PDF
Loading

Figures & Tables

Tables

    • View popup
    TABLE 1.

    Review of PrEP for PLP Language in National HIV Strategic Plans, National HIV Guidelines, and PEPFAR COPsa

    CountryNational HIV Strategic Plan
    (Plan Years)
    National HIV Guidelines 2013–2017
    (Publication Year)
    National HIV Guidelines 2017–2020
    (Publication Year)
    COP 2018
    (FY 19)
    COP 2019
    (FY 20)
    COP 2020
    (FY 21)
    BotswanaN
    (2010–2016)b
    Limited (2016)N/ANSLimitedY
    CameroonNS
    (2018–2022)
    X
    (2015)
    N/ANSNSNS
    Côte d’IvoireN
    (2015–2019)
    N/ANS
    (2019)
    NSNSY
    Democratic Republic of the CongoN
    (2018–2021)
    Limited (2016)NS
    (2018)
    NNSNS
    EswatiniY
    (2018–2023)
    N
    (2015)
    N/ANSYY
    HaitiNS
    (2018–2023)
    N
    (2013)
    N/ANSNSNS
    KenyaNS
    (2020–2024)
    Limited (2016)Limited
    (2018)
    NSNSY
    LesothoY
    (2018–2023)
    NS
    (2016)
    N/ANSYY
    MalawiNS
    (2015–2020)
    X
    (2016)
    Y
    (2019)
    NSYY
    MozambiqueLimited
    (2020–2024)
    N
    (2015)
    N/ANSNSY
    NamibiaY
    (2017–2022)
    Limited (2016)Y
    (2019)
    NSYY
    NigeriaNS
    (2017–2021)
    NS
    (2016)
    N/AXNSY
    RwandaNS
    (2013–2020)
    N
    (2016)
    Limited
    (2018)
    NSNSY
    South AfricaNS
    (2017–2022)
    Y
    (2016)
    Y
    (2019)
    NSNSY
    United Republic of TanzaniaLimited
    (2017–2022)
    N
    (2015)
    NS
    (2019)
    NSNSY
    UgandaNS
    (2015–2020)
    NS
    (2016)
    Limited
    (2018)
    YNSY
    ZambiaNS
    (2017–2021)
    Y
    (2016)
    Y
    (2020)
    LimitedYY
    ZimbabweNS
    (2015–2020)
    Limited
    (2016)
    Limited (2019)NSYY
    • Abbreviations: COP, country operational plan; DREAMS, Determined, Resilient, Empowered, AIDS-free, Mentored, and Safe; FY, fiscal year; PEPFAR, U.S. President’s Emergency Plan for AIDS Relief; PLP, pregnant and lactating people; PrEP, preexposure prophylaxis; SDC, serodifferent couple.

    • aClassification of PrEP for PLP language in these documents: Y, PrEP specified for PLP as a priority population; Limited, PrEP specified for PLP in limited circumstances (SDCs, DREAMS participants, etc.);

    • NS, PrEP specified as a prevention method, but PLP not specified; X, PrEP specified as a prevention method, but not approved or included for implementation; N, PrEP not specified or mentioned at all; N/A, Document does not exist or was not available.

    • ↵bThere was no publicly available national strategic plan that included the time period after 2017.

    • View popup
    TABLE 2.

    Review of National HIV Strategic Plans

    Document CategoriesCountries, %(No.)
    PrEP specified for PLP under any circumstance (i.e., as a priority population or in limitedcircumstances)28 (5)
     PrEP specified for PLP as a priority population17 (3)a
     PrEP specified for PLP in limited circumstances11 (2)b
    PrEP specified as a prevention method but PLP not specified56 (10)c
    PrEP specified as a prevention method but not approved or included for implementation0
    PrEP not specified or mentioned at all17 (3)d
    Total reviewed18
    • Abbreviation: PLP, pregnant and lactating people; PrEP, preexposure prophylaxis.

    • ↵a Eswatini, Lesotho, and Namibia.

    • ↵b Mozambique and United Republic of Tanzania.

    • ↵c Cameroon, Haiti, Kenya, Malawi, Nigeria, Rwanda, South Africa, Uganda, Zambia, and Zimbabwe.

    • ↵d Botswana, Cote d’Ivoire, and Democratic Republic of the Congo.

    • View popup
    TABLE 3.

    Review of National HIV Guidelines, Pre-2017 and Post-2017

    Document Categories2013–2017, % (No.)2017–2020, % (No.) 
    PrEP specified for PLP under any circumstance (i.e., as a priority population or in limited circumstances)41 (7)73 (8)
     PrEP specified for PLP as a priority population12 (2)a36 (4)b
     PrEP specified for PLP in limited circumstances29 (5)c36 (4)d
    PrEP specified as a prevention method but PLP not specified18 (3)e27 (3)f
    PrEP specified as a prevention method but not approved or included for implementation12 (2)g0
    PrEP not specified or mentioned at all29 (5)h0
    Total reviewed1711
    • Abbreviations: PLP, pregnant and lactating people; PrEP, preexposure prophylaxis.

    • ↵aSouth Africa and Zambia.

    • ↵bMalawi, Namibia, South Africa, and Zambia.

    • ↵cBotswana, Democratic Republic of the Congo, Kenya, Namibia, and Zimbabwe.

    • ↵dKenya, Rwanda, Uganda, and Zimbabwe.

    • ↵eLesotho, Nigeria, and Uganda.

    • ↵fCote d’Ivoire, Democratic Republic of the Congo, and United Republic of Tanzania.

    • ↵gCameroon and Malawi.

    • ↵hEswatini, Haiti, Mozambique, Rwanda, and United Republic of Tanzania.

    • View popup
    TABLE 4.

    Review of PEPFAR COPs, 2018–2020

    Document Categories2018, % (No.)2019, % (No.)2020, % (No.)
    PrEP specified for PLP under any circumstance (i.e., as a priority population or in limited circumstances)11 (2)39 (7)83 (15)
     PrEP specified for PLP as a priority population6 (1)a33 (6)b83 (15)c
     PrEP specified for PLP in limited circumstances6 (1)d6 (1)e0
    PrEP specified as a prevention method but PLP not specified78 (14)f61 (11)g17 (3)h
    PrEP specified as a prevention method but not approved or included for implementation6 (1)i00
    PrEP not specified or mentioned at all6 (1)j00
    Total reviewed, No.181818
    • Abbreviations: COP, country operational plan; PLP, pregnant and lactating people; PEPFAR, U.S. President’s Emergency Plan for AIDS Relief; PrEP, preexposure prophylaxis.

    • ↵a Uganda.

    • ↵b Eswatini, Lesotho, Malawi, Namibia, Zambia, and Zimbabwe.

    • ↵c Botswana, Cote d’Ivoire, Eswatini, Kenya, Lesotho, Malawi, Mozambique, Namibia, Nigeria, Rwanda, South Africa, United Republic of Tanzania, Uganda, Zambia, and Zimbabwe.

    • ↵d Zimbabwe.

    • ↵e Botswana.

    • ↵f Botswana, Cameroon, Cote d’Ivoire, Eswatini, Haiti, Kenya, Lesotho, Malawi, Mozambique, Namibia, Rwanda, South Africa, United Republic of Tanzania, and Zimbabwe.

    • ↵g Cameroon, Cote d’Ivoire, Democratic Republic of the Congo, Haiti, Kenya, Mozambique, Nigeria, Rwanda, South Africa, United Republic of Tanzania, and Uganda.

    • ↵h Cameroon, Democratic Republic of the Congo, and Haiti.

    • ↵i Nigeria.

    • ↵j Democratic Republic of the Congo.

PreviousNext
Back to top

In this issue

Global Health: Science and Practice: 10 (6)
Global Health: Science and Practice
Vol. 10, No. 6
December 21, 2022
  • Table of Contents
  • About the Cover
  • Index by Author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Global Health: Science and Practice.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Preexposure Prophylaxis Among Pregnant and Lactating People in 18 PEPFAR-Supported Countries: A Review of HIV Strategies and Guidelines
(Your Name) has forwarded a page to you from Global Health: Science and Practice
(Your Name) thought you would like to see this page from the Global Health: Science and Practice web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Preexposure Prophylaxis Among Pregnant and Lactating People in 18 PEPFAR-Supported Countries: A Review of HIV Strategies and Guidelines
Sheena Sharifi Abadan, Liz Hawryluk, Michele Montandon, Nicole Flowers, Jane Schueller, Robyn Eakle, Pragna Patel, Michelle S. Chevalier, Sangeeta Rana, Anouk Amzel
Global Health: Science and Practice Dec 2022, 10 (6) e2200129; DOI: 10.9745/GHSP-D-22-00129

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Preexposure Prophylaxis Among Pregnant and Lactating People in 18 PEPFAR-Supported Countries: A Review of HIV Strategies and Guidelines
Sheena Sharifi Abadan, Liz Hawryluk, Michele Montandon, Nicole Flowers, Jane Schueller, Robyn Eakle, Pragna Patel, Michelle S. Chevalier, Sangeeta Rana, Anouk Amzel
Global Health: Science and Practice Dec 2022, 10 (6) e2200129; DOI: 10.9745/GHSP-D-22-00129
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Statistics from Altmetric.com

Jump to section

  • Article
    • ABSTRACT
    • INTRODUCTION
    • METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Funding
    • Author contributions
    • Disclaimer
    • Competing interests
    • Notes
    • REFERENCES
  • Figures & Tables
  • Info & Metrics
  • Comments
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Assessing the Generalizability of Client Experience Measurement Tools in Low- and Middle-Income Countries: A Narrative Review
  • Narrative Review of Human-Centered Design in Public Health Interventions in Low- and Middle-Income Countries: Recommendations for Practice, Research, and Reporting
  • Simulation-Based Education of Health Workers in Low- and Middle-Income Countries: A Systematic Review
Show more REVIEW

Similar Articles

Subjects

  • Health Topics
    • HIV/AIDS
    • Infectious Diseases
    • Maternal, Newborn, and Child Health
Johns Hopkins Center for Communication Programs

Follow Us On

  • LinkedIn
  • Facebook
  • RSS

Articles

  • Current Issue
  • Advance Access Articles
  • Past Issues
  • Topic Collections
  • Most Read Articles
  • Supplements

More Information

  • Submit a Paper
  • Instructions for Authors
  • Instructions for Reviewers

About

  • About GHSP
  • Advisory Board
  • FAQs
  • Privacy Policy
  • Contact Us

© 2026 Creative Commons Attribution 4.0 International License. ISSN: 2169-575X

Powered by HighWire